Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 6.81 USD 1.19% Market Closed
Market Cap: 392.8m USD

Kamada Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kamada Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Revenue
$174.8m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
10%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$96.5m
CAGR 3-Years
16%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$124k
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Revenue
$1.3m
CAGR 3-Years
60%
CAGR 5-Years
125%
CAGR 10-Years
13%
M
Matricelf Ltd
TASE:MTLF
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kamada Ltd
Glance View

Market Cap
392.8m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
HIDDEN
Show

See Also

What is Kamada Ltd's Revenue?
Revenue
174.8m USD

Based on the financial report for Sep 30, 2025, Kamada Ltd's Revenue amounts to 174.8m USD.

What is Kamada Ltd's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Kamada Ltd have been 15% over the past three years , 5% over the past five years , and 10% over the past ten years .

Back to Top